Skip to main content

Table 8 Summary of the outcome assessment schedule

From: Statistical analysis plan for an international, double-blind, randomized controlled clinical trial on the use of phantom motor execution as a treatment for phantom limb pain

Session Summary of content
Visit 0 • Patient information (T/E)
• Study consent (T/E)
• Pre-assessment (T/E)
• Background information (T/E)
• Q-PLP (T/E)
• PDI (T/E)
• EQ-5D-5L (T/E)
• PSEQ-2 (T/E)
• PCS-SF (T/E)
• PHQ-2 (T/E)
• EXPECT-SF (T/E)
Randomization
Visit 1 • Treatment session (T)
• Q-PLP (E)
• OAT (E)
• EXPECT-SF (E)
• HCCQ-SF (E)
Visit 2–14 • Treatment session (T)
• Q-PLP (E)
Visit 15 • Treatment session (T)
• Q-PLP (E)
• PDI (E)
• EQ-5D-5L (E)
• PSEQ-2 (E)
• PCS-SF (E)
• PHQ-2 (E)
• PGIC (E)
• HCCQ-SF (E)
1-month follow-up • Q-PLP (E)
• PDI (E)
• EQ-5D-5L (E)
• PSEQ-2 (E)
• PCS-SF (E)
• PHQ-2 (E)
3-month follow-up
6-month follow-up
  1. Abbreviations: Q-PLP Questionnaire for Phantom Limb Pain, PDI Pain Disability Index, PSEQ-2 2-item Pain Self-Efficacy Questionnaire, EQ-5D-5L Euroqol-5D-5L, PCS-SF Pain Catastrophizing Scale Short Form, PHQ-2 2-item Patient Health Questionnaire, PGIC Patients’ Global Impression of Change, OAT Opinion About Treatment, HCCQ Health Care Climate Questionnaire, EXPECT-SF Expectations for Complementary and Alternative Medicine Treatments Short Form